Related Experiment Video

Updated: Jul 14, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Mirk/Dyrk1B in cancer

Eileen Friedman1

  • 1Pathology Department, Upstate Medical University, State University of New York, 750 East Adams Street, Syracuse, New York, USA. friedmae@upstate.edu

Journal of Cellular Biochemistry
|June 23, 2007
PubMed

Insights

Mirk/Dyrk1B kinase regulates cell cycle and apoptosis, playing a role in cancer. Inhibiting Mirk may enhance chemotherapy effectiveness against tumor cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Mirk/Dyrk1B is a serine/threonine kinase involved in tissue differentiation.
  • It regulates skeletal muscle cell cycle arrest and apoptosis.
  • Mirk gene amplification and activation are observed in various cancers.

Purpose of the Study:

  • To investigate the role of Mirk kinase in cancer cell proliferation and survival.
  • To explore Mirk's activation pathway by stress-activated SAPK kinases.
  • To evaluate the potential of Mirk inhibition as a cancer therapy.

Main Methods:

  • RNA interference (RNAi) to deplete Mirk expression.
  • Assessing colony formation in cancer cell lines.
  • Evaluating apoptosis induction by chemotherapeutic drugs.

Main Results:

  • Mirk depletion reduced cancer cell colony formation.
  • Mirk depletion enhanced chemotherapy-induced apoptosis.
  • Mirk is activated by MKK3 and MKK6 stress kinases.

Conclusions:

  • Mirk acts as a checkpoint kinase, arresting damaged tumor cells in a quiescent state for repair.
  • Pharmacological inhibition of Mirk could potentiate anti-cancer drug efficacy.

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...